Cargando…

Association of sarcopenia with survival in advanced NSCLC patients receiving concurrent immunotherapy and chemotherapy

BACKGROUND: Frailty, sarcopenia and malnutrition are powerful predictors of clinical outcomes that are not routinely measured in patients with non-small cell lung cancer (NSCLC). The primary aim of this study was to investigate the association of sarcopenia, determined by the psoas muscle index (PMI...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bolte, Fabian J., McTavish, Sloane, Wakefield, Nathan, Shantzer, Lindsey, Hubbard, Caroline, Krishnaraj, Arun, Novicoff, Wendy, Gentzler, Ryan D., Hall, Richard D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9539742/ https://www.ncbi.nlm.nih.gov/pubmed/36212442 http://dx.doi.org/10.3389/fonc.2022.986236

Ejemplares similares

Modeling Sarcopenia to Predict Survival for Patients With Nasopharyngeal Carcinoma Receiving Concurrent Chemoradiotherapy
por: Hua, Xin, et al.
Publicado: (2021)

Book Review: Les enfants des limbes: mort-nés et parents dans l' Europe chrétienne
por: McTavish, Lianne
Publicado: (2007)

Blame and Vindication in the Early Modern Birthing Chamber
por: McTAVISH, LIANNE
Publicado: (2006)

On est ensemble: social capital and maternal health care use in rural Cameroon
por: McTavish, Sarah, et al.
Publicado: (2015)

Pretreatment SUV(max) value to predict outcome in patients with stage III NSCLC receiving concurrent chemoradiotherapy
por: Yaprak, Gokhan, et al.
Publicado: (2019)

How do SNP ascertainment schemes and population demographics affect inferences about population history?
por: McTavish, Emily Jane, et al.
Publicado: (2015)

A Genomic Approach for Distinguishing between Recent and Ancient Admixture as Applied to Cattle
por: McTavish, Emily Jane, et al.
Publicado: (2014)

The Landscape of Immunotherapy Resistance in NSCLC
por: Frisone, Daniele, et al.
Publicado: (2022)

Gating effects along mitral cell lateral dendrites
por: McTavish, Thomas, et al.
Publicado: (2007)

Recent Advances in Immunotherapy in Metastatic NSCLC
por: Bansal, Pranshu, et al.
Publicado: (2016)

Immunotherapy and NSCLC: The Long and Winding Road
por: Rossi, Antonio
Publicado: (2020)

Immunotherapy in NSCLC Patients with Brain Metastases
por: Buriolla, Silvia, et al.
Publicado: (2022)

Cryobiopsy for pneumonitis diagnosis in NSCLC immunotherapy
por: Zarogoulidis, Paul, et al.
Publicado: (2022)

Erratum: The landscape of immunotherapy resistance in NSCLC
Publicado: (2023)

Glucocorticoids can activate the α-ENaC gene promoter independently of SGK1
por: McTavish, Niall, et al.
Publicado: (2009)

Physcraper: a Python package for continually updated phylogenetic trees using the Open Tree of Life
por: Sánchez-Reyes, Luna L., et al.
Publicado: (2021)

Color Polymorphism is a Driver of Diversification in the Lizard Family Lacertidae
por: Brock, Kinsey M, et al.
Publicado: (2021)

Survival Is Worse in Patients Completing Immunotherapy Prior to SBRT/SRS Compared to Those Receiving It Concurrently or After
por: Woody, Susan, et al.
Publicado: (2022)

Functional Roles of Distributed Synaptic Clusters in the Mitral–Granule Cell Network of the Olfactory Bulb
por: Migliore, Michele, et al.
Publicado: (2010)

Mitral cell spike synchrony modulated by dendrodendritic synapse location
por: McTavish, Thomas S., et al.
Publicado: (2012)

Evaluation of hospital staff’s perceived quality of librarian-mediated literature searching services,
por: McKeown, Sandra, et al.
Publicado: (2017)

Foster children’s perspectives on participation in child welfare processes: A meta-synthesis of qualitative studies
por: McTavish, Jill R., et al.
Publicado: (2022)

Review and perspective on adjuvant and neoadjuvant immunotherapies in NSCLC
por: Yi, Chengxiang, et al.
Publicado: (2019)

Pleurodesis and Immunotherapy in NSCLC; Medical Thoracoscopy or VATS?
por: Zarogoulidis, Paul, et al.
Publicado: (2020)

Immunotherapy for Stage III NSCLC: Durvalumab and Beyond
por: Fitzpatrick, Orla, et al.
Publicado: (2021)

Exploring the Evolving Scope of Neoadjuvant Immunotherapy in NSCLC
por: Roller, John F., et al.
Publicado: (2022)

Immunotherapy in NSCLC Patients With Brain and Leptomeningeal Metastases
por: Pierret, Thomas, et al.
Publicado: (2022)

Impact of NSCLC metabolic remodeling on immunotherapy effectiveness
por: Lv, Lulu, et al.
Publicado: (2022)

Editorial: Immunotherapy for NSCLC with oncogenic driver variants
por: Du, Yijia, et al.
Publicado: (2022)

Circulating Biomarkers for Prediction of Immunotherapy Response in NSCLC
por: Goh, Kah Yee, et al.
Publicado: (2023)

Erlotinib and Concurrent Chemoradiation in Pretreated NSCLC Patients: Radiobiological Basis and Clinical Results
por: Ramella, Sara, et al.
Publicado: (2013)

Sarcopenia among patients receiving hemodialysis: weighing the evidence
por: Kittiskulnam, Piyawan, et al.
Publicado: (2016)

Frailty and Sarcopenia in Older Patients Receiving Kidney Transplantation
por: Gandolfini, Ilaria, et al.
Publicado: (2019)

Pan-immune-inflammation and its dynamics: predictors of survival and immune-related adverse events in patients with advanced NSCLC receiving immunotherapy
por: Chen, Yiqun, et al.
Publicado: (2023)

Relevance of the Updated Recursive Partitioning Analysis (U-RPA) Classification in the Contemporary Care of Patients with Brain Metastases
por: Fadul, Camilo E., et al.
Publicado: (2023)

Comprehensive assessment of pretreatment sarcopenia impacts on patients with EGFR ‐mutated NSCLC treated with afatinib
por: Wu, Chen‐Te, et al.
Publicado: (2023)

Noise attenuation varies by interactions of land cover and season in an urban/peri-urban landscape
por: Gaudon, Justin M., et al.
Publicado: (2022)

Decision‐making around resuscitation of extremely preterm infants in the Philippines: A consensus guideline
por: Wilkinson, Dominic JC, et al.
Publicado: (2019)

Quality of Life in Patients with NSCLC Receiving Maintenance Therapy
por: Rittmeyer, Achim
Publicado: (2015)

Statins and immunotherapy: Togetherness makes strength The potential effect of statins on immunotherapy for NSCLC
por: Rossi, Alessandro, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4d9htqeecc8d2rk5mke9q2pdgi